BONESUPPORT Doubled Its North American Sales in 2023 Company Revenue The Numbers The company grew nearly 80% in 2023, with 104% growth in North America on the strength of CERAMENT G sales in the U.S. Mar 08, 2024
Top Orthopedic Executives Look Back on 2023 Executive Insights Industry Voices We gathered quotes from top orthopedic executives as they reflected on enabling technology, procedure demand and M&A integration progress. Mar 07, 2024
Orthofix to Fully Leverage Enabling Tech Under New Leadership Company Revenue The Numbers The company grew in the mid-single-digits on a pro forma basis in 2023 and is focused on leveraging its unique place in the market. Mar 06, 2024
Paragon 28 Looks to Scale for Next Phase of Growth Company Revenue The Numbers The company grew 19% in 2023 despite contending with supply chain constraints and could growth another 20% in 2024. Mar 04, 2024
Vericel’s MACI Arthro to Drive Growth for Years Company Revenue The Numbers The company's MACI revenues grew nearly 25% in 2023 and Vericel expects the launch of MACI Arthro in the third quarter of 2024. Mar 04, 2024
ATEC Thrives in Disrupted Spine Market Company Revenue The Numbers The company grew more than 37% in 2023 as its procedural solutions win over surgeons in a disrupted spine market. Mar 01, 2024
Stryker Talks Tidal Wave Opportunity for Total Ankle Replacement Executive Insights Industry Voices We talked to Michael Rankin about Stryker's view of enabling technology in foot and ankle as well as future demand in the ASC. Feb 29, 2024
Treace Medical Foresees Extended Growth Runway Company Revenue The Numbers The company grew more than 30% in 2023 and added another $750 million to its already massive $5 billion total addressable market. Feb 29, 2024
Smith+Nephew’s Fix for Orthopedics Remains Work in Progress Company Revenue The Numbers The company's orthopedic sales grew in the mid-single-digits for 2023 but were hamstrung by supply constraints and headwinds in China. Feb 28, 2024
Enovis Set to Maintain Double-Digit Recon Growth in 2024 Company Revenue The Numbers The company's orthopedic sales grew in the mid-teens for 2023 and is likely to be a $1 billion recon player in 2024. Feb 26, 2024